Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study

Kate M Chitty; Elizabeth Evans; Jennifer J Torr; Teresa Iacono; Henry Brodaty; Perminder Sachdev; Julian N Trollor

doi:10.1177/0004867415587951

Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study

Kate M Chitty, Elizabeth Evans, Jennifer J Torr, Teresa Iacono, Henry Brodaty, Perminder Sachdev, Julian N Trollor

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.

Original language	English
Pages (from-to)	352-362
Number of pages	11
Journal	Australian & New Zealand Journal of Psychiatry
Volume	50
Issue number	4
DOIs	https://doi.org/10.1177/0004867415587951
Publication status	Published - 2016

Keywords

intellectual disability
challenging behaviour
central nervous system medication
polypharmacy

Access to Document

10.1177/0004867415587951

http://www.ncbi.nlm.nih.gov/pubmed/26019276

Cite this

Chitty, Kate M ; Evans, Elizabeth ; Torr, Jennifer J ; Iacono, Teresa ; Brodaty, Henry ; Sachdev, Perminder ; Trollor, Julian N. / Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study. In: Australian & New Zealand Journal of Psychiatry. 2016 ; Vol. 50, No. 4. pp. 352-362.

@article{91068244c28242f39e3be0dafbd5b34a,

title = "Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study",

abstract = "Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.",

keywords = "intellectual disability, challenging behaviour, central nervous system medication, polypharmacy",

author = "Chitty, {Kate M} and Elizabeth Evans and Torr, {Jennifer J} and Teresa Iacono and Henry Brodaty and Perminder Sachdev and Trollor, {Julian N}",

year = "2016",

doi = "10.1177/0004867415587951",

language = "English",

volume = "50",

pages = "352--362",

journal = "Australian & New Zealand Journal of Psychiatry",

issn = "0004-8674",

publisher = "SAGE Publications Ltd",

number = "4",

}

Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study. / Chitty, Kate M; Evans, Elizabeth; Torr, Jennifer J; Iacono, Teresa; Brodaty, Henry; Sachdev, Perminder; Trollor, Julian N.

In: Australian & New Zealand Journal of Psychiatry, Vol. 50, No. 4, 2016, p. 352-362.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study

AU - Chitty, Kate M

AU - Evans, Elizabeth

AU - Torr, Jennifer J

AU - Iacono, Teresa

AU - Brodaty, Henry

AU - Sachdev, Perminder

AU - Trollor, Julian N

PY - 2016

Y1 - 2016

N2 - Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.

AB - Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.

KW - intellectual disability

KW - challenging behaviour

KW - central nervous system medication

KW - polypharmacy

UR - http://www.ncbi.nlm.nih.gov/pubmed/26019276

U2 - 10.1177/0004867415587951

DO - 10.1177/0004867415587951

M3 - Article

VL - 50

SP - 352

EP - 362

JO - Australian & New Zealand Journal of Psychiatry

JF - Australian & New Zealand Journal of Psychiatry

SN - 0004-8674

IS - 4

ER -